CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 211 enrolled
Drug / intervention
Cocoa Flavanoldietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02312310
NCT02312310N/ACompleted
CompareCT.gov

Dietary Cocoa Flavanols and Age-Related Memory Decline

New York State Psychiatric Institute·interventional·Posted Dec 9, 2014·Updated Jun 11, 2020

In Brief

A clinical study evaluating Cocoa Flavanol for Memory Loss. Completed, enrolled 211 participants across 1 site.

Detailed Summary

to assess the effect of differing amounts of a cocoa-derived dietary flavanol (epicatechin ) on dentate gyrus function and corresponding cognitive function

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMemory Loss
CountriesUnited States
CollaboratorsMars, Inc.

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 9, 2014
Enrollment StartDec 1, 2015
Primary CompletionNov 1, 2018
Study CompletionApr 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 11.6 years ago

Interventions

Cocoa Flavanoldietary

12 weeks administration of cocoa flavanol